Clinical Trials Directory

Trials / Conditions / Collecting Duct Carcinoma

Collecting Duct Carcinoma

6 registered clinical trials studyying Collecting Duct Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingPembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
NCT06302569
Giuseppe ProcopioPhase 2
RecruitingStudy to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
NCT06211114
Peking University Cancer Hospital & InstitutePhase 2
WithdrawnPamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
NCT04603365
Jonsson Comprehensive Cancer CenterPhase 2
UnknownCollecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)
NCT05372302
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano—
Active Not RecruitingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) f
NCT04071223
National Cancer Institute (NCI)Phase 2
RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted
NCT03866382
National Cancer Institute (NCI)Phase 2